← Eichor
Study identifier: NCT05855889 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Observational Study of the Management of Infants With Congenital CMV

Condition: Congenital Cmv  ·  Sponsor: St George's, University of London

PhaseN/A
Planned participants200
Who can joinAll sexes, N/A to 10 Years
Healthy volunteersNo

About this study

This is an observational, prospective/retrospective multicentre, cohort study of children diagnosed with cCMV. This study will contribute to a wider study also recruiting participants in Europe and other countries worldwide. No investigations or treatment will be carried out that are not part of routine clinical practice. Infants with cCMV are routinely followed up from an infectious diseases, audiology, ophthalmology and neurodevelopmental perspective until approximately 6 years of age, or longer if there are ongoing issues. Some children will be retrospectively diagnosed with cCMV in later childhood. Recruitment can be from any centre that manages these patients and has agreed to participate in the study.

This description comes directly from the study's public registry record.

Talk to the study team

Sana Ibrahim, BSc  ·  +44 (0)208 725 5382  ·  sibrahim@sgul.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

St George's University of LondonLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05855889